AstraZeneca PLC (AZN) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 15.29B | 15.5B | 15.19B | 14.46B | 13.59B | 14.89B | 13.56B | 12.94B | 12.68B | 12.02B | 11.49B | 11.42B |
| Revenue Growth % | 12.51% | 4.11% | 11.99% | 11.74% | 7.17% | 23.84% | 18.04% | 13.33% | 16.55% | 7.29% | 4.64% | 5.99% |
| Cost of Goods Sold | 2.68B | 3.12B | 2.8B | 2.47B | 2.24B | 2.73B | 3.08B | 2.18B | 2.22B | 2.31B | 2.1B | 1.96B |
| COGS % of Revenue | 17.52% | 20.11% | 18.44% | 17.11% | 16.49% | 18.3% | 22.71% | 16.87% | 17.49% | 19.19% | 18.23% | 17.17% |
| Gross Profit | 12.61B | 12.38B | 12.39B | 11.98B | 11.35B | 12.17B | 10.48B | 10.76B | 10.46B | 9.72B | 9.4B | 9.46B |
| Gross Margin % | 82.48% | 79.89% | 81.56% | 82.89% | 83.51% | 81.7% | 77.29% | 83.13% | 82.51% | 80.81% | 81.77% | 82.83% |
| Gross Profit Growth % | 11.13% | 1.8% | 18.18% | 11.43% | 8.47% | 25.22% | 11.57% | 13.74% | 16.57% | 16.96% | 17.46% | 21.65% |
| Operating Expenses | 8.36B | 9.41B | 8.81B | 8.48B | 7.67B | 10.13B | 8.38B | 8.01B | 7.35B | 8.48B | 7.44B | 7B |
| OpEx % of Revenue | 54.71% | 60.68% | 57.98% | 58.63% | 56.47% | 68.03% | 61.76% | 61.9% | 57.94% | 70.54% | 64.77% | 61.32% |
| Selling, General & Admin | 5.06B | 5.64B | 5.23B | 5.01B | 4.63B | 5.55B | 5.29B | 5.06B | 4.63B | 5.52B | 4.93B | 5.12B |
| SG&A % of Revenue | 33.1% | 36.41% | 34.45% | 34.63% | 34.05% | 37.29% | 38.98% | 39.12% | 36.52% | 45.87% | 42.89% | 44.82% |
| Research & Development | 3.49B | 3.86B | 3.66B | 3.55B | 3.16B | 4.68B | 3.12B | 3.01B | 2.78B | 3.07B | 2.58B | 2.67B |
| R&D % of Revenue | 22.84% | 24.91% | 24.11% | 24.54% | 23.25% | 31.41% | 22.96% | 23.25% | 21.95% | 25.56% | 22.49% | 23.36% |
| Other Operating Expenses | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | 4.25B | 2.98B | 3.58B | 3.51B | 3.67B | 2.04B | 2.11B | 2.75B | 3.12B | 1.23B | 1.95B | 2.46B |
| Operating Margin % | 27.77% | 19.21% | 23.59% | 24.27% | 27.04% | 13.67% | 15.53% | 21.22% | 24.57% | 10.26% | 17% | 21.51% |
| Operating Income Growth % | 15.57% | 46.27% | 70.13% | 27.75% | 17.95% | 64.99% | 7.78% | 11.81% | 22.2% | 12.8% | 56.95% | 355.66% |
| EBITDA | 5.61B | 4.49B | 5.13B | 4.9B | 4.96B | 2.75B | 3.92B | 4.03B | 4.37B | 2.56B | 3.24B | 3.73B |
| EBITDA Margin % | 36.71% | 28.96% | 33.78% | 33.87% | 36.49% | 18.47% | 28.92% | 31.11% | 34.47% | 21.3% | 28.16% | 32.69% |
| EBITDA Growth % | 13.19% | 63.24% | 30.82% | 21.66% | 13.46% | 7.38% | 21.23% | 7.85% | 7.87% | 9.07% | 25.47% | 96.84% |
| D&A (Non-Cash Add-back) | 1.37B | 1.51B | 1.55B | 1.39B | 1.28B | 714M | 1.82B | 1.28B | 1.25B | 1.33B | 1.28B | 1.28B |
| EBIT | 4.31B | 3.1B | 3.68B | 3.57B | 3.75B | 2.1B | 2.29B | 2.84B | 3.21B | 1.34B | 2.04B | 2.52B |
| Net Interest Income | -320M | -349M | -349M | -371M | -265M | -365M | -274M | -343M | -302M | -337M | -291M | -367M |
| Interest Income | 73M | 123M | 85M | 68M | 84M | 64M | 183M | 100M | 111M | 108M | 101M | 64M |
| Interest Expense | 393M | 472M | 434M | 439M | 349M | 429M | 457M | 443M | 413M | 445M | 392M | 431M |
| Other Income/Expense | -332M | -349M | -339M | -381M | -272M | -370M | -278M | -349M | -315M | -337M | -302M | -368M |
| Pretax Income | 3.91B | 2.63B | 3.24B | 3.13B | 3.4B | 1.67B | 1.83B | 2.4B | 2.8B | 897M | 1.65B | 2.09B |
| Pretax Margin % | 25.6% | 16.96% | 21.35% | 21.63% | 25.04% | 11.19% | 13.48% | 18.53% | 22.08% | 7.46% | 14.38% | 18.29% |
| Income Tax | 833M | 300M | 709M | 679M | 481M | 166M | 395M | 469M | 620M | -62M | 274M | 268M |
| Effective Tax Rate % | 21.28% | 11.41% | 21.86% | 21.71% | 14.14% | 9.96% | 21.61% | 19.57% | 22.14% | -6.91% | 16.59% | 12.84% |
| Net Income | 3.08B | 2.33B | 2.53B | 2.45B | 2.92B | 1.5B | 1.43B | 1.93B | 2.18B | 960M | 1.37B | 1.82B |
| Net Margin % | 20.15% | 15% | 16.67% | 16.95% | 21.46% | 10.07% | 10.53% | 14.89% | 17.19% | 7.98% | 11.96% | 15.93% |
| Net Income Growth % | 5.62% | 55.07% | 77.26% | 27.14% | 33.82% | 56.25% | 4% | 6% | 20.85% | 6.55% | -16.22% | 405% |
| Net Income (Continuing) | 3.08B | 2.33B | 2.54B | 2.45B | 2.92B | 1.5B | 1.43B | 1.93B | 2.18B | 959M | 1.38B | 1.82B |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 51M | 52M | 83M | 91M | 92M | 85M | 86M | 86M | 56M | 23M | 24M | 24M |
| EPS (Diluted) | 1.97 | 1.48 | 1.62 | 1.57 | 1.87 | 0.96 | 0.92 | 1.24 | 1.40 | 0.61 | 0.88 | 1.17 |
| EPS Growth % | 5.35% | 54.17% | 76.09% | 26.61% | 33.57% | 57.38% | 4.55% | 5.98% | 20.69% | 5.17% | -16.19% | 408.7% |
| EPS (Basic) | 1.99 | 1.51 | 1.63 | 1.58 | 1.88 | 0.97 | 0.92 | 1.24 | 1.41 | 0.61 | 0.89 | 1.17 |
| Diluted Shares Outstanding | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B |
| Basic Shares Outstanding | 1.55B | 1.55B | 1.56B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B |
| Dividend Payout Ratio | 106.72% | 0.53% | 63.27% | 0.41% | 114.78% | 0.2% | 110.29% | 0.88% | 139.19% | 0.21% | 102.62% | 1.21% |